...Thank you, Mary. And good morning, everyone. We appreciate you joining us on our call today. Beginning on Slide 3, I'm happy to report that amidst a seemingly worsening economic backdrop, Aptar achieved core sales growth of 9% and delivered adjusted EPS of $0.95 per share, which is the midpoint of our previously given guidance range. The majority of the growth in the quarter was driven by our Pharma segment. Later on in our call, Bob Kuhn, our CFO, will provide additional details on the quarter. I would like to cover a few key items now. Our adjusted earnings per share includes the previously announced onetime inflation payment made to certain European employees that increased to approximately $0.05 a share. Our industry-leading Pharma segment grew across all end markets, with prescription consumer health care and active materials being particularly strong....
